AUA白皮书:非神经源性慢性尿潴留的共识定义、治疗流程与结局终点
美国泌尿外科学会质量改进与患者安全委员会基于文献回顾与专家组共识制定白皮书,将非神经源性慢性尿潴留定义为排尿后残余尿量大于300 mL、持续至少6个月且在至少2次不同场合记录;按风险(高/低)与症状(有/无症状)分层并制定治疗流程,提出4项疗效评估结局终点。
要点
- 非神经源性慢性尿潴留定义为排尿后残余尿量大于300 mL、持续至少6个月且至少2次不同场合记录。
- 高风险的判定包括影像学肾积水、3期慢性肾脏病、反复培养证实的尿路感染或尿脓毒症。
- 治疗流程先按风险分层、再按症状分层,并提出症状改善、风险降低、成功试排尿拔管、症状与风险长期稳定4项结局终点。
核心结论
- 对非神经源性慢性尿潴留进行定义与分类、制定治疗流程并提出治疗结局终点,有望推动比较研究,最终更好地理解这一具有挑战性的疾病。
研究设计与样本
- 美国泌尿外科学会(AUA)质量改进与患者安全(QIPS)委员会基于文献回顾与工作组共识专家意见制定白皮书。
主要发现
- 工作组将非神经源性慢性尿潴留定义为排尿后残余尿量大于300 mL、持续至少6个月且在至少2次不同场合记录。
- 建议慢性尿潴留按风险(高 vs 低)与症状(有症状 vs 无症状)分类。
- 高风险慢性尿潴留定义为影像学肾积水、3期慢性肾脏病、反复培养证实的尿路感染或尿脓毒症。
- 有症状慢性尿潴留定义为主观中重度泌尿症状影响生活质量,和/或近期有导尿史。
- 提出应评估的4项主要结局以判定尿潴留治疗的有效性:症状改善、风险降低、无导尿的成功试排尿、症状与风险随时间保持稳定。
关键数值与推荐
- 非神经源性慢性尿潴留:排尿后残余尿量大于300 mL,持续至少6个月,且在至少2次不同场合记录。
- 高风险慢性尿潴留:影像学肾积水、3期慢性肾脏病、反复培养证实的尿路感染或尿脓毒症。
- 有症状慢性尿潴留:主观中重度泌尿症状影响生活质量,和/或近期有导尿史。
- 治疗流程:先按风险分层,再按症状分层。
- 疗效评估的4项主要结局:症状改善、风险降低、无导尿的成功试排尿、症状与风险随时间保持稳定。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The AUA (American Urological Association) QIPS (Quality Improvement and Patient Safety) committee created a white paper on the diagnosis and management of nonneurogenic chronic urinary retention. MATERIALS AND METHODS: Recommendations for the white paper were based on a review of the literature and consensus expert opinion from the workgroup. RESULTS: The workgroup defined nonneurogenic chronic urinary retention as an elevated post-void residual of greater than 300 mL that persisted for at least 6 months and documented on 2 or more separate occasions. It is proposed that chronic urinary retention should be categorized by risk (high vs low) and symptomatology (symptomatic versus asymptomatic). High risk chronic urinary retention was defined as hydronephrosis on imaging, stage 3 chronic kidney disease or recurrent culture proven urinary tract infection or urosepsis. Symptomatic chronic urinary retention was defined as subjectively moderate to severe urinary symptoms impacting quality of life and/or a recent history of catheterization. A treatment algorithm was developed predicated on stratifying patients with chronic urinary retention first by risk and then by symptoms. The proposed 4 primary outcomes that should be assessed to determine effectiveness of retention treatment are 1) symptom improvement, 2) risk reduction, 3) successful trial of voiding without catheterization, and 4) stability of symptoms and risk over time. CONCLUSIONS: Defining and categorizing nonneurogenic chronic urinary retention, creating a treatment algorithm and proposing treatment end points will hopefully spur comparative research that will ultimately lead to a better understanding of this challenging condition.
引用
- Stoffel JT, Peterson AC, Sandhu JS, et al. AUA White Paper on Nonneurogenic Chronic Urinary Retention: Consensus Definition, Treatment Algorithm, and Outcome End Points. J Urol. 2017. PMID: 28163030. doi:10.1016/j.juro.2017.01.075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。